Andrew Foxley, BA on Phase III Trial of Capivasertib and Paclitaxel: Importance of this Trial #ASCO2020 @AstraZeneca #ASCO

Andrew Foxley, BA on Phase III Trial of Capivasertib and Paclitaxel: Importance of this Trial #ASCO2020 @AstraZeneca #ASCO

User Photo
Cancer-News

1 month
2 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Andrew Foxley, BA of AstraZeneca @AstraZeneca discusses a phase III trial of capivasertib and paclitaxel in first-line treatment of patients with metastatic triple-negative breast cancer.

Read here: https://meetinglibrary.asco.org/record/191881/abstract

Up Next Autoplay
User Photo